Review
Cardiovascular toxicity and tricyclic antidepressants
Affiliations
- PMID: 3328632
Item in Clipboard
Review
Cardiovascular toxicity and tricyclic antidepressants
Biomed Pharmacother.
1987.
Abstract
This article reviews the cardiovascular effects of the standard tricyclic antidepressants and what is known of the cardiovascular effects of the newer antidepressants. The cardiovascular effects of the standard tricyclics are orthostatic hypotension, conduction delay and a potent antiarrhythmic effect. Patients who have congestive heart failure and are on cardiac medications are at greatly increased risk for orthostatic hypotension, while patients who have pre-existing conduction delay are at risk for heart block.
Similar articles
-
Cardiovascular effects of antidepressants.J Clin Psychiatry. 1982 Nov;43(11 Pt 2):22-9. J Clin Psychiatry. 1982. PMID: 6816788
-
Cardiovascular effects of the antidepressants: recognition and control.Geriatrics. 1990 Jan;45(1):55-9, 62, 67. Geriatrics. 1990. PMID: 1688541 Review.
-
Depression, heart disease, and tricyclic antidepressants.J Clin Psychiatry. 1989 Jul;50 Suppl:12-6; discussion 17. J Clin Psychiatry. 1989. PMID: 2661547 Review.
-
Cardiovascular effects of therapeutic doses of tricyclic antidepressants: importance of blood level monitoring.J Clin Psychiatry. 1980 Dec;41(12 Pt 2):57-63. J Clin Psychiatry. 1980. PMID: 7440526
-
Monoamine oxidase inhibitors and tricyclic antidepressants: comparison of their cardiovascular effects.J Clin Psychiatry. 1986 May;47(5):225-9. J Clin Psychiatry. 1986. PMID: 3516976 Review.
Cited by
-
Glutamatergic systems in neuropathic pain and emerging non-opioid therapies.Pharmacol Res. 2022 Nov;185:106492. doi: 10.1016/j.phrs.2022.106492. Epub 2022 Oct 10. Pharmacol Res. 2022. PMID: 36228868 Free PMC article. Review.